This might contribute to UPR-induced enhanced O-GlcNAcylation, which in turn will allow survival of AML cells as increased O-GlcNAcylation abrogates the UPR induced apoptosis through disrupting the PERK-CHOP pathway (53). This evidence concerns the gene EIF2AK3 and acute myeloid leukemia.